90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma.
Saved in:
| Title: | 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma. |
|---|---|
| Authors: | Janik JE; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Morris JC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, O'Mahony D; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Pittaluga S; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Jaffe ES; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Redon CE; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Bonner WM; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Brechbiel MW; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Paik CH; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Whatley M; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Chen C; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Lee JH; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Fleisher TA; Immunology Service, Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Brown M; Immunology Service, Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, White JD; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Stewart DM; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Fioravanti S; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Lee CC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Goldman CK; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Bryant BR; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Junghans RP; Department of Medicine, Roger Williams Medical Center, Providence, RI 02908., Carrasquillo JA; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;, Worthy T; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Corcoran E; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Conlon KC; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;, Waldmann TA; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; tawald@helix.nih.gov. |
| Source: | Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2015 Oct 20; Vol. 112 (42), pp. 13045-50. Date of Electronic Publication: 2015 Oct 05. |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26438866 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Janik+JE%22">Janik JE</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Morris+JC%22">Morris JC</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22O'Mahony+D%22">O'Mahony D</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Pittaluga+S%22">Pittaluga S</searchLink>; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Jaffe+ES%22">Jaffe ES</searchLink>; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Redon+CE%22">Redon CE</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Bonner+WM%22">Bonner WM</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Brechbiel+MW%22">Brechbiel MW</searchLink>; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Paik+CH%22">Paik CH</searchLink>; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Whatley+M%22">Whatley M</searchLink>; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink>; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Fleisher+TA%22">Fleisher TA</searchLink>; Immunology Service, Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Brown+M%22">Brown M</searchLink>; Immunology Service, Clinical Pathology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22White+JD%22">White JD</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Stewart+DM%22">Stewart DM</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Fioravanti+S%22">Fioravanti S</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Lee+CC%22">Lee CC</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Goldman+CK%22">Goldman CK</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Bryant+BR%22">Bryant BR</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Junghans+RP%22">Junghans RP</searchLink>; Department of Medicine, Roger Williams Medical Center, Providence, RI 02908.<br /><searchLink fieldCode="AU" term="%22Carrasquillo+JA%22">Carrasquillo JA</searchLink>; Nuclear Medicine Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Worthy+T%22">Worthy T</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Corcoran+E%22">Corcoran E</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Conlon+KC%22">Conlon KC</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892;<br /><searchLink fieldCode="AU" term="%22Waldmann+TA%22">Waldmann TA</searchLink>; Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; tawald@helix.nih.gov. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227505876%22">Proceedings of the National Academy of Sciences of the United States of America</searchLink> [Proc Natl Acad Sci U S A] 2015 Oct 20; Vol. 112 (42), pp. 13045-50. <i>Date of Electronic Publication: </i>2015 Oct 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Intramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22National+Academy+of+Sciences%22">National Academy of Sciences </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7505876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1091-6490 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200278424%22">00278424 </searchLink><i>NLM ISO Abbreviation: </i>Proc Natl Acad Sci U S A <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26438866 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1073/pnas.1516107112 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 13045 Titles: – TitleFull: 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Janik JE – PersonEntity: Name: NameFull: Morris JC – PersonEntity: Name: NameFull: O'Mahony D – PersonEntity: Name: NameFull: Pittaluga S – PersonEntity: Name: NameFull: Jaffe ES – PersonEntity: Name: NameFull: Redon CE – PersonEntity: Name: NameFull: Bonner WM – PersonEntity: Name: NameFull: Brechbiel MW – PersonEntity: Name: NameFull: Paik CH – PersonEntity: Name: NameFull: Whatley M – PersonEntity: Name: NameFull: Chen C – PersonEntity: Name: NameFull: Lee JH – PersonEntity: Name: NameFull: Fleisher TA – PersonEntity: Name: NameFull: Brown M – PersonEntity: Name: NameFull: White JD – PersonEntity: Name: NameFull: Stewart DM – PersonEntity: Name: NameFull: Fioravanti S – PersonEntity: Name: NameFull: Lee CC – PersonEntity: Name: NameFull: Goldman CK – PersonEntity: Name: NameFull: Bryant BR – PersonEntity: Name: NameFull: Junghans RP – PersonEntity: Name: NameFull: Carrasquillo JA – PersonEntity: Name: NameFull: Worthy T – PersonEntity: Name: NameFull: Corcoran E – PersonEntity: Name: NameFull: Conlon KC – PersonEntity: Name: NameFull: Waldmann TA IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 10 Text: 2015 Oct 20 Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1091-6490 Numbering: – Type: volume Value: 112 – Type: issue Value: 42 Titles: – TitleFull: Proceedings of the National Academy of Sciences of the United States of America Type: main |
| ResultId | 1 |